ArticleSTAR protocols2022

A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19.

Sophie Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.